SK392592A3 - Pressure aerosol composition - Google Patents

Pressure aerosol composition Download PDF

Info

Publication number
SK392592A3
SK392592A3 SK3925-92A SK392592A SK392592A3 SK 392592 A3 SK392592 A3 SK 392592A3 SK 392592 A SK392592 A SK 392592A SK 392592 A3 SK392592 A3 SK 392592A3
Authority
SK
Slovakia
Prior art keywords
propellant
surfactant
aerosol composition
pressurized aerosol
surfactants
Prior art date
Application number
SK3925-92A
Other languages
English (en)
Slovak (sk)
Inventor
Asit Somani
Clive Booles
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909014526A external-priority patent/GB9014526D0/en
Priority claimed from GB909014527A external-priority patent/GB9014527D0/en
Priority claimed from GB909023953A external-priority patent/GB9023953D0/en
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of SK392592A3 publication Critical patent/SK392592A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fertilizers (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SK3925-92A 1990-06-29 1991-06-25 Pressure aerosol composition SK392592A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB909014526A GB9014526D0 (en) 1990-06-29 1990-06-29 Aerosol formulation
GB909014527A GB9014527D0 (en) 1990-06-29 1990-06-29 Aerosol formulation
GB909023953A GB9023953D0 (en) 1990-11-03 1990-11-03 Pharmaceutical composition
PCT/GB1991/001023 WO1992000061A1 (fr) 1990-06-29 1991-06-25 Compositions d'aerosol pressurisees

Publications (1)

Publication Number Publication Date
SK392592A3 true SK392592A3 (en) 1994-07-06

Family

ID=27265168

Family Applications (1)

Application Number Title Priority Date Filing Date
SK3925-92A SK392592A3 (en) 1990-06-29 1991-06-25 Pressure aerosol composition

Country Status (21)

Country Link
US (1) US5846521A (fr)
EP (1) EP0536235B1 (fr)
JP (1) JP2854974B2 (fr)
AT (1) ATE147973T1 (fr)
AU (1) AU8055691A (fr)
BR (1) BR9106595A (fr)
CA (1) CA2085884C (fr)
CZ (1) CZ392592A3 (fr)
DE (1) DE69124374T2 (fr)
DK (1) DK0536235T3 (fr)
ES (1) ES2096653T3 (fr)
FI (1) FI925852A (fr)
GR (1) GR3023065T3 (fr)
HU (1) HUT63554A (fr)
IE (1) IE912220A1 (fr)
MX (1) MX9100008A (fr)
NO (1) NO924954D0 (fr)
NZ (1) NZ238746A (fr)
PT (1) PT98133A (fr)
SK (1) SK392592A3 (fr)
WO (1) WO1992000061A1 (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776434A (en) 1988-12-06 1998-07-07 Riker Laboratories, Inc. Medicinal aerosol formulations
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5785952A (en) * 1990-11-09 1998-07-28 Glaxo Group Limited Aerosol medicament formulation having a surface coating of surfactant
EP1005860A1 (fr) 1991-06-10 2000-06-07 Schering Corporation Formulations d'aérosols sans chlorofluorohydrocarbures
PT656207E (pt) * 1991-06-10 2001-11-30 Schering Corp Formulacoes de aerossois sem clorofluorocarbonetos
CA2421976C (fr) 1991-12-12 2004-04-20 Glaxo Group Limited Medicaments
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US5376359A (en) * 1992-07-07 1994-12-27 Glaxo, Inc. Method of stabilizing aerosol formulations
MX9304585A (es) * 1992-07-31 1994-03-31 Glaxo Group Ltd Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata.
DE69413955T2 (de) * 1993-03-17 1999-04-01 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Aerosolzusammensetzung enthaltend einen aus ester-, amid- oder merkaptoester- derivat dispergiermittel
US6042811A (en) * 1993-03-17 2000-03-28 3M Innovative Properties Company Aerosol formulation containing a diol-diacid derived dispersing aid
US5593661A (en) * 1993-03-29 1997-01-14 Henry; Richard A. Lidocaine aerosol anaesthetic
JPH09506097A (ja) * 1993-12-02 1997-06-17 アボツト・ラボラトリーズ 非ｃｆｃ噴射剤と共に用いるエアロゾル薬物調剤
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5635159A (en) * 1994-08-26 1997-06-03 Abbott Laboratories Aerosol drug formulations containing polyglycolyzed glycerides
US5635161A (en) * 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
PT1014943E (pt) 1997-02-05 2002-11-29 Jago Res Ag Formulacoes medicinais de aerossois
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
GB9805938D0 (en) 1998-03-19 1998-05-13 Glaxo Group Ltd Valve for aerosol container
GB9807232D0 (en) 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6585958B1 (en) 1998-07-24 2003-07-01 Jago Research Ag Medicinal aerosol formulations
DE59904648D1 (de) 1998-08-04 2003-04-24 Jago Res Ag Muttenz Medizinische aerosolformulierungen
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US6451287B1 (en) 2000-05-26 2002-09-17 Smithkline Beecham Corporation Fluorinated copolymer surfactants and use thereof in aerosol compositions
EP1318973A2 (fr) 2000-09-22 2003-06-18 Glaxo Group Limited Nouveaux derives d'acide alcanoique
JP2005504715A (ja) 2000-12-29 2005-02-17 アドバンスト インハレーション リサーチ，インコーポレイテッド 持続放出特性を有する吸入用粒子
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
GB0125127D0 (en) 2001-10-19 2001-12-12 Glaxo Group Ltd Compounds
EP1458360B1 (fr) 2001-12-19 2011-05-11 Novartis AG Administration pulmonaire d'aminoglycosides
EP1458357B1 (fr) * 2001-12-21 2009-03-04 3M Innovative Properties Company Compositions aerosols pharmaceutiques comportant un excipient au polyethylene-glycol fonctionnalise
CA2474626A1 (fr) 2002-02-13 2003-08-21 Glaxo Group Limited Composes d'acide carboxylique a utiliser comme agents de surface
GB0205327D0 (en) * 2002-03-06 2002-04-17 Glaxo Group Ltd compounds
MXPA06001642A (es) 2003-08-11 2006-04-28 Glaxo Group Ltd Inhalador farmaceutico de dosis medida y metodos relacionados con el mismo.
MXPA06002075A (es) 2003-08-29 2006-05-19 Glaxo Group Ltd Inhalador de dosis farmaceutica medida y metodos relacionados.
JP5825757B2 (ja) 2007-02-11 2015-12-02 マップ・ファーマシューティカルズ・インコーポレイテッド 副作用プロファイルを最小限にしながら片頭痛の迅速な緩和を可能にするｄｈｅの治療上の投与方法
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
EP3174522A1 (fr) 2014-07-29 2017-06-07 3M Innovative Properties Company Procédé de préparation d'une composition pharmaceutique

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7708731A (nl) * 1976-08-13 1978-02-15 Montedison Spa Werkwijze voor de bereiding van nieuwe drijf- middelsamenstellingen voor aerosolen.
CA1136547A (fr) * 1979-03-08 1982-11-30 Song-Ling Lin Compose anesthesique en aerosol
GB8432063D0 (en) * 1984-12-19 1985-01-30 Riker Laboratories Inc Physically modified steroids
WO1988007855A1 (fr) * 1987-04-09 1988-10-20 Fisons Plc Compositions pharmaceutiques contenant de la pentamidine
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB8828544D0 (en) * 1988-12-07 1989-01-11 Ici Plc Chemical process
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
GB8908250D0 (en) * 1989-04-12 1989-05-24 Fisons Plc Formulations
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments

Also Published As

Publication number Publication date
DK0536235T3 (da) 1997-04-14
NO924954L (no) 1992-12-21
MX9100008A (es) 1992-02-03
NO924954D0 (no) 1992-12-21
US5846521A (en) 1998-12-08
EP0536235B1 (fr) 1997-01-22
DE69124374D1 (de) 1997-03-06
EP0536235A1 (fr) 1993-04-14
ATE147973T1 (de) 1997-02-15
ES2096653T3 (es) 1997-03-16
DE69124374T2 (de) 1997-06-19
AU8055691A (en) 1992-01-23
JPH05507712A (ja) 1993-11-04
CA2085884A1 (fr) 1991-12-30
GR3023065T3 (en) 1997-07-30
NZ238746A (en) 1992-10-28
FI925852A0 (fi) 1992-12-23
CZ392592A3 (en) 1993-05-12
PT98133A (pt) 1992-04-30
FI925852A (fi) 1992-12-23
JP2854974B2 (ja) 1999-02-10
IE912220A1 (en) 1992-01-01
HUT63554A (en) 1993-09-28
WO1992000061A1 (fr) 1992-01-09
HU9204098D0 (en) 1993-03-29
CA2085884C (fr) 2001-12-04
BR9106595A (pt) 1993-04-20

Similar Documents

Publication Publication Date Title
SK392592A3 (en) Pressure aerosol composition
EP0755247B1 (fr) Aerosols medicamenteux contenant un gaz propulseur a base d'hydrofluorocarbones
CA2074495C (fr) Melanges propulsifs
JP3323199B2 (ja) クロロフルオロカーボン不含エアゾール製剤
JP3142136B2 (ja) 加圧エアロゾル組成物
KR100696746B1 (ko) 가압화되고 계량되는 도스흡입기
CA2402300C (fr) Medicaments aerosols avec propulseur fluorocarbone
JPH10510521A (ja) エアゾール処方物用噴射剤混合物
SK13342003A3 (sk) Lekárske aerosólové prípravky
SK140593A3 (en) Non-chlorofluorocarbon aerosol formulations
EP1140059A2 (fr) Formulations pharmaceutiques d'aerosols contenant des fluoroalcanes, du budesonide et du formoterol
CZ184694A3 (en) Pharmaceutical preparation
PL193721B1 (pl) Kompozycja do stosowania w inhalatorze aerozolowym, sposób napełniania inhalatora tą kompozycją oraz zastosowanie składnika niskolotnego
AU2369000A (en) Pharmaceutical aerosol formulations containing fluoroalkanes and budesonide
IL98666A (en) Pressurized aerosol preparations
SK278930B6 (sk) Antiastmatický aerosolový prípravok